Literature DB >> 19546368

Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates.

J A G Ferreira1, J H Carr, C E F Starling, M A de Resende, R M Donlan.   

Abstract

Candida biofilms are microbial communities, embedded in a polymeric matrix, growing attached to a surface, and are highly recalcitrant to antimicrobial therapy. These biofilms exhibit enhanced resistance against most antifungal agents except echinocandins and lipid formulations of amphotericin B. In this study, biofilm formation by different Candida species, particularly Candida albicans, C. tropicalis, and C. parapsilosis, was evaluated, and the effect of caspofungin (CAS) was assessed using a clinically relevant in vitro model system. CAS displayed in vitro activity against C. albicans and C. tropicalis cells within biofilms. Biofilm formation was evaluated after 48 h of antifungal drug exposure, and the effects of CAS on preformed Candida species biofilms were visualized using scanning electron microscopy (SEM). Several species-specific differences in the cellular morphologies associated with biofilms were observed. Our results confirmed the presence of paradoxical growth (PG) in C. albicans and C. tropicalis biofilms in the presence of high CAS concentrations. These findings were also confirmed by SEM analysis and were associated with the metabolic activity obtained by biofilm susceptibility testing. Importantly, these results suggest that the presence of atypical, enlarged, conical cells could be associated with PG and with tolerant cells in Candida species biofilm populations. The clinical implications of these findings are still unknown.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546368      PMCID: PMC2764222          DOI: 10.1128/AAC.00316-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  54 in total

Review 1.  Biofilm, city of microbes.

Authors:  P Watnick; R Kolter
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

Review 2.  Candida biofilms: antifungal resistance and emerging therapeutic options.

Authors:  Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Curr Opin Investig Drugs       Date:  2004-02

3.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 4.  Candida biofilms.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2002-12       Impact factor: 7.934

5.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

Review 6.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole.

Authors:  Carolina Mateus; Sidney A Crow; Donald G Ahearn
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.

Authors:  Analy S Melo; Arnaldo L Colombo; Beth A Arthington-Skaggs
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

View more
  24 in total

1.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors:  Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal:  J Med Microbiol       Date:  2011-06-23       Impact factor: 2.472

3.  Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.

Authors:  Anscha Mari Troskie; Marina Rautenbach; Nicolas Delattin; Johan Arnold Vosloo; Margitta Dathe; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 4.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

5.  Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Authors:  Margarida Martins; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycoses       Date:  2011-06-12       Impact factor: 4.377

6.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

7.  In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.

Authors:  Kwan Soo Ko; Ji-Young Lee; Jae-Hoon Song; Kyong Ran Peck
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

8.  Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.

Authors:  Carla J Walraven; Stella M Bernardo; Nathan P Wiederhold; Samuel A Lee
Journal:  Med Mycol       Date:  2013-12-22       Impact factor: 4.076

9.  Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.

Authors:  Cristina Rueda; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

10.  In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.

Authors:  Taissa Vieira Machado Vila; Ashok K Chaturvedi; Sonia Rozental; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.